Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Tegoprazan Tablets

Tegolasen tablets are a drug developed by Luoxin Pharmaceuticals for the treatment of reflux esophagitis.
On April 13, 2022, Luoxin Pharmaceuticals announced that its subsidiary Shandong Luoxin received the “Drug Registration Certificate” for Tegolasen tablets for the treatment of reflux esophagitis approved and issued by the National Medical Products Administration. [1]

Share:

Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.